, Tracking Stock Market Picks
Enter Symbol:

up 1,031.77 %

MEDIVATION INC (MDVN) rated Buy with price target $26 by Stanford Research

Posted on: Tuesday,  Jan 29, 2008  8:25 AM ET by Stanford Research

Stanford Research rated Buy MEDIVATION INC (NASDAQ: MDVN) on 01/29/2008, when the stock price was $8.14. Since
then, MEDIVATION INC has gained 1031.78% as of 01/27/2016's recent price of $92.07.
If you would have followed this Stanford Research's recommendation on MDVN, you would have gained 1031.77% of your investment in 2920 days.

Medivation, Inc. is a biopharmaceutical company with small molecule drugs in clinical development to treat three medical needs: Alzheimer?s disease, Huntington?s disease and castration-resistant prostate cancer. The Company has formed separate subsidiaries to hold the product candidates it is developing. The Company?s subsidiary Medivation Neurology, Inc. holds its Dimebon technology, and its subsidiary Medivation Prostate Therapeutics, Inc. holds its MDV300 series technology.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/29/2008 8:25 AM Buy
8.14 13.00
as of 12/24/2008
1 Week up  9.27 %
1 Month up  12.92 %
3 Months up  8.16 %
1 YTD up  39.12 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy